FI782793A - 3-(2-hydroxi-4-(substituerad)fenyl)azacykloalkaner och derivater av dessa saosom analgetiska medel och mellanprodukter foer dessa - Google Patents

3-(2-hydroxi-4-(substituerad)fenyl)azacykloalkaner och derivater av dessa saosom analgetiska medel och mellanprodukter foer dessa

Info

Publication number
FI782793A
FI782793A FI782793A FI782793A FI782793A FI 782793 A FI782793 A FI 782793A FI 782793 A FI782793 A FI 782793A FI 782793 A FI782793 A FI 782793A FI 782793 A FI782793 A FI 782793A
Authority
FI
Finland
Prior art keywords
dessa
och
derivater
azacycloalkaner
saosom
Prior art date
Application number
FI782793A
Other languages
English (en)
Other versions
FI66173C (fi
FI66173B (fi
Inventor
Thomas Henry Althuis
Charles Armon Harbert
Michael Ross Johnson
Jr Lawrence Sherman Melvin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI782793A publication Critical patent/FI782793A/fi
Application granted granted Critical
Publication of FI66173B publication Critical patent/FI66173B/fi
Publication of FI66173C publication Critical patent/FI66173C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
FI782793A 1977-09-13 1978-09-12 Foerfarande foer framstaellning av terapeutiskt anvaendbara -(2-hydroxifenyl)-azacykloalkanderivat FI66173C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83286977 1977-09-13
US05/832,869 US4147872A (en) 1977-09-13 1977-09-13 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor

Publications (3)

Publication Number Publication Date
FI782793A true FI782793A (fi) 1979-03-14
FI66173B FI66173B (fi) 1984-05-31
FI66173C FI66173C (fi) 1984-09-10

Family

ID=25262819

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782793A FI66173C (fi) 1977-09-13 1978-09-12 Foerfarande foer framstaellning av terapeutiskt anvaendbara -(2-hydroxifenyl)-azacykloalkanderivat

Country Status (23)

Country Link
US (1) US4147872A (fi)
JP (5) JPS5935397B2 (fi)
AR (2) AR222019A1 (fi)
AT (1) AT368753B (fi)
AU (1) AU507953B1 (fi)
BE (1) BE870403A (fi)
CA (1) CA1113463A (fi)
CH (1) CH638187A5 (fi)
DE (1) DE2839883A1 (fi)
DK (1) DK401078A (fi)
ES (2) ES473287A1 (fi)
FI (1) FI66173C (fi)
FR (4) FR2401913A1 (fi)
GB (1) GB2004548B (fi)
IE (1) IE47717B1 (fi)
IL (1) IL55555A (fi)
IT (1) IT1099026B (fi)
LU (1) LU80219A1 (fi)
NL (1) NL7809272A (fi)
PH (1) PH15372A (fi)
PT (1) PT68542A (fi)
SE (2) SE7809606L (fi)
YU (1) YU215678A (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
FI792076A (fi) * 1978-07-05 1980-01-06 Ciba Geigy Ag Foerfarande foer framstaellning av nya fenylpiperidinderivat
US4302590A (en) * 1979-02-23 1981-11-24 Hoechst-Roussel Pharmaceuticals, Inc. Intermediates for the preparation of 4-aryloxy-3-phenylpiperidines
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
US4312876A (en) * 1979-02-23 1982-01-26 Hoechst-Roussel Pharmaceuticals Incorporated Antidepressive and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
ZA821888B (en) * 1981-04-01 1983-02-23 Haessle Ab Novel phenyl-piperidines
US4709016A (en) * 1982-02-01 1987-11-24 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4529732A (en) * 1983-03-14 1985-07-16 Pfizer Inc. 2-[2-Hydroxy-4-(substituted)phenyl]piperidines
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN1671639A (zh) * 2002-08-23 2005-09-21 康涅狄格大学 新型联苯大麻素和类似联苯的大麻素
DE102004036349A1 (de) * 2004-07-27 2006-03-23 Grünenthal GmbH Substituierte 3-Phenylpiperidin-Derivate
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
BR112015019208A2 (pt) * 2013-02-14 2017-07-18 Galderma Res & Dev processo de síntese

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310761A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives de la phenyl-piperidine et leurs sels, procede de preparation et application a titre de medicaments

Also Published As

Publication number Publication date
AT368753B (de) 1982-11-10
IE781837L (en) 1979-03-13
CH638187A5 (fr) 1983-09-15
SE7809606L (sv) 1979-03-14
CA1113463A (en) 1981-12-01
ES473287A1 (es) 1980-03-01
DK401078A (da) 1979-03-14
FI66173C (fi) 1984-09-10
GB2004548B (en) 1982-03-24
FR2401913B1 (fi) 1983-01-21
IT7827557A0 (it) 1978-09-12
FI66173B (fi) 1984-05-31
FR2412530A1 (fr) 1979-07-20
JPS5640155B2 (fi) 1981-09-18
AU507953B1 (en) 1980-03-06
PH15372A (en) 1982-12-10
FR2412531B1 (fi) 1983-01-14
DE2839883A1 (de) 1979-03-15
IL55555A (en) 1982-08-31
FR2412529B1 (fi) 1983-01-14
SE8305422D0 (sv) 1983-10-03
SE8305422L (sv) 1983-10-03
FR2412530B1 (fi) 1982-11-12
ATA658078A (de) 1982-03-15
JPS5538366A (en) 1980-03-17
AR220567A1 (es) 1980-11-14
FR2412529A1 (fr) 1979-07-20
IT1099026B (it) 1985-09-18
US4147872A (en) 1979-04-03
LU80219A1 (fr) 1980-04-21
FR2412531A1 (fr) 1979-07-20
FR2401913A1 (fr) 1979-03-30
JPS5935397B2 (ja) 1984-08-28
BE870403A (fr) 1979-03-12
AR222019A1 (es) 1981-04-15
YU215678A (en) 1983-06-30
IL55555A0 (en) 1978-12-17
PT68542A (en) 1978-10-01
JPS5538365A (en) 1980-03-17
JPS5463086A (en) 1979-05-21
ES480151A1 (es) 1980-04-01
NL7809272A (nl) 1979-03-15
IE47717B1 (en) 1984-05-30
JPS5495577A (en) 1979-07-28
GB2004548A (en) 1979-04-04
JPS5492973A (en) 1979-07-23

Similar Documents

Publication Publication Date Title
FI780963A (fi) Foerfarande foer framstaellning av jodoforfoereningar och foerfarande foer stabilisering av dessa innehaollande farmaceutiska jodoforsammansaettningar
FI782793A (fi) 3-(2-hydroxi-4-(substituerad)fenyl)azacykloalkaner och derivater av dessa saosom analgetiska medel och mellanprodukter foer dessa
FI54772B (fi) Foerfarande och anordning foer kantning av braede
FI773880A (fi) Foerfarande foer framstaellning av en raefflad vals och motsvarande vals
FI773108A (fi) Foerfarande och anordning foer maetning av traevirke
FI54594B (fi) Kombination av biologisk torrtoalett och biologisk rengoeringsanlaeggning foer avloppsvatten
FI780345A (fi) Testfoerpackning och foerfarande foer utvaerdering av lp-x
FI781114A (fi) Foerfarande foer rengoering och rostskyddande av en metallyta
FI771853A (fi) Foerfarande foer foerbaettringar av olika cementers haordningshastighet och haollfasthet
NO783323L (no) Nye fenyl-isotiocyanat-derivater
FI781911A (fi) Foerfarande foer framstaellning av sirap och substrat
FI773094A (fi) Bindemedel och foerfarande foer framstaellning av detsamma
FI780126A (fi) Loesning av sublimerande faergaemnen saerskilt i och foer framstaellning av specialblaeck foer filtmarkerare eller-pennor
FI783903A (fi) Saett och anordning foer tillverkning av hylsor
FI783378A (fi) Saett foer utdragning av linor och upphaengning i stolpar
FI780787A (fi) Foerfarande och anordning foer reglering av krossar
FI780981A (fi) Blykristaller innehaollande battericeller och av dessa framstaellda batterianordningar
FI780731A (fi) Slutsanordning och saett foer utgoerande av densamma
FI772406A (fi) Glidgjutmaskin foer framstaellning av haolplattor och liknande
FI783944A (fi) 5-(2-anilino-alkylamino-1-hydroxialkyl)-salicylamider deras framstaellning och deras anvaendning saosom antihypertensiver
FI790025A (fi) Amider och hydrazider av laongkedjiga aminosyror och deras cyklopropananaloger deras framstaellning och deras anvaendning saosom antiaterosklerotiska medel
FI782237A (fi) 3-(1-pyrazolyl)-pyridazinderivat och foerfarande foer deras framstaellning
FI780382A (fi) Azetizinonderivater och framstaellning av desamma
FI780941A (fi) Sprutpressbart kollagenhoelje och foerfarande foer framstaellning av detsamma
FI783086A (fi) Foerbraenningsfoerfarande i en 2-taktsmaskin och 2-taktsmaskin foer foerverkligande av foerfarandet

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.